P56817 (BACE1_HUMAN) Homo sapiens (Human)

Beta-secretase 1 UniProtKBInterProSTRINGInteractive Modelling

501 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6); 2 identical sequences: Pan troglodytes: A0A803KHP3, K7BR34

Available Structures

431 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH ACTIVE SITE AND EXOSITE BINDING PEPTIDE INHIBITOR Heteromer
56-448
100EDO;
Structure Basis of Allosteric Inhibition of BACE1 by an Exosite-Binding Antibody Heteromer
57-447
100.0
VHS domain of human GGA1 complexed with C-terminal phosphopeptide from BACE Heteromer
Q9UJY5;
495-501
100IOD;
Complex of GGA1-VHS domain and beta-secretase C-terminal phosphopeptide Heteromer
Q9UJY5;
495-501
100
VHS domain of human GGA1 complexed with C-terminal peptide from BACE Heteromer
Q9UJY5;
495-501
100
Structure of BACE bound to SCH346572homo-2-mer53-447
100G00;
Structure of BACE bound to SCH12472homo-2-mer53-447
100D8Y;
Crystal Structure of Human Beta Secretase Complexed with inhibitorhomo-2-mer56-446
99.47QIN;
Structure of BACE Bound to (S)-4-(3'-methoxy-[1,1'-biphenyl]-3-yl)-1,4-dimethyl-6-oxotetrahydropyri…homo-2-mer58-447
100H24;TLA;
Structure of BACE Bound to SCH743641homo-2-mer58-447
100TLA;Z75;
Structure of BACE bound to SCH708236homo-2-mer58-447
100.03TO;TLA;
Structure of BACE Bound to SCH747123homo-2-mer58-447
100TLA;Z76;
Structure of BACE Bound to SCH745132homo-2-mer58-447
100TLA;Z74;
X-ray crystal structure of beta secretase complexed with compound 27homo-2-mer60-447
100.0IOD;C27;
X-ray crystal structure of beta secretase complexed with compound 24homo-2-mer60-447
100.0IOD;H24;
X-ray crystal structure of beta secretase complexed with compound 8chomo-2-mer60-447
100.0IOD;C8C;
Crystal Structure of Human Beta Secretase Complexed with Spiropiperdine Iminohydantoin Inhibitorhomo-2-mer58-444
99.46SII;
Crystal structure of beta-site app-cleaving enzyme 1 (bace-wt) complex with bms-681889 aka n~1~-but…homo-2-mer60-446
1003HH;SO4;GOL;
Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with bms-655295 aka n~3~-((1…homo-2-mer60-446
1003HF;IOD;GOL;
Structure of BACE complexed to compound 3ahomo-2-mer62-446
98.963MR;
BACE1 compound 28monomer37-445
99.47B7E;
Synthesis, Characterization and PK/PD Studies of a Series of Spirocyclic Pyranochromene BACE1 Inhib…monomer57-453
100.0NI;2X4;
Synthesis, Characterization and PK/PD Studies of a Series of Spirocyclic Pyranochromene BACE1 Inhib…monomer57-453
100.0NI;2X5;
Aminooxazoline inhibitor of BACE-1monomer58-453
100NI;1WP;
Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 Inhibitorsmonomer58-453
100.0ZN;1B8;
Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 Inhibitorsmonomer58-453
100.0ZN;1B9;
Spirocyclic Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitorsmonomer58-453
100NI;1M4;
Spirocyclic Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitorsmonomer58-453
100NI;1M5;
Spirocyclic Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitorsmonomer58-453
100NI;1M7;
Spirocyclic Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitorsmonomer58-453
100NI;1M6;
Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 Inhibitorsmonomer58-453
100.0ZN;1BF;
Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the cataly…monomer58-453
100.0ZN;0ZA;
Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the cataly…monomer58-453
100.0ZN;1CH;
SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitorsmonomer58-453
100.0ZN;842;
Structure of BACE Bound to SCH589432monomer53-447
100CS5;
Crystal Structure of BACE with Compound 14gmonomer60-453
100.00UP;ZN;
Crystal Structure of BACE with Compound 1monomer60-453
100.0091;EDO;ZN;
8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzy…monomer60-453
100.0NI;3UX;
8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzy…monomer60-453
100.0NI;3UY;
Discovery of 7-THP chromans: BACE1 inhibitors that reduce A-beta in the CNSmonomer60-453
100.0NI;2EX;
8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzy…monomer60-453
100.0NI;3UW;
Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the cataly…monomer60-453
100.01BB;ZN;
8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzy…monomer60-453
100.0NI;3J9;
Crystal Structure of BACE with Compound 5monomer60-453
100.0092;EDO;PEG;ZN;
Crystal Structure of BACE with Compound 12amonomer60-453
100.00UQ;ZN;EDO;
Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 Inhibitorsmonomer60-453
100.0ZN;1B7;
Crystal Structure of BACE with Compound 8monomer60-453
100.009A;ZN;EDO;PEG;
Crystal Structure of BACE with Compound 12monomer60-453
100.009D;EDO;PEG;ZN;
Crystal Structure of BACE with Compound 14monomer60-453
100.009F;EDO;PEG;ZN;
Crystal structure of human BACE-1 bound to Compound 24Bmonomer60-453
100.03VO;
Crystal Structure of BACE with Compound 11monomer60-453
100.009G;EDO;PEG;ZN;
Design and synthesis of thiophene dihydroisoquinolins as novel BACE-1 inhibitorsmonomer60-453
100.0ZN;1BE;
Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the cataly…monomer60-453
100.0ZN;1BS;
Crystal Structure of BACE with Compound 9monomer60-453
100.009B;EDO;PEG;ZN;
Crystal Structure of BACE with Compound 6monomer60-453
100.0095;EDO;PEG;ZN;
Crystal Structure of BACE with Compound 13monomer60-453
100.009E;
BACE-1 in complex with compound #32monomer54-446
100QKA;GOL;SO4;
BACE crystal structure with hydroxy pyrrolidine inhibitormonomer54-446
100DJV;GOL;
BACE crystal structure with hydroxy pyrrolidine inhibitormonomer54-446
100DJS;GOL;
BACE-1 in complex with compound #17monomer54-446
100QJV;GOL;SO4;
BACE crystal structure with hydroxy morpholine inhibitormonomer54-446
100DK7;GOL;
Structure of BACE1 bound to SCH626485monomer55-447
100CS5;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH ACTIVE SITE INHIBITOR GRL-8234 AND EXOSITE PEPTIDEmonomer55-447
99.74BSD;
Crystal structure of BACE1 with a pyrazole-substituted tetrahydropyran thioamidinemonomer57-448
100.0SI5;IOD;GOL;DMS;
Crystal Structure of BACE1 in complex with (S)-N-(3-(2-amino-6-(fluoromethyl)-4 -methyl-4H-1,3-oxaz…monomer55-446
100.0IOD;GOL;0B6;
Crystal structure of BACE-1 in complex with inhibitormonomer56-447
99.47CL;012;
Crystal Structure of BACE1 in complex with N-(3-((4S,5S)-2-amino-4-methyl-5-phenyl-5,6-dihydro-4H-1…monomer57-448
100.0IOD;DMS;C7X;
APO Structure of BACE1monomer56-447
99.46SO4;
Crystal structure of BACE-1 in complex with inhibitormonomer56-447
99.47009;
BACE-1 in complex with compound #6monomer56-446
100ZQS;
BACE-1 in complex with compound #34monomer56-446
100QK7;GOL;
BACE1 in complex with (R)-N-(3-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2H-1,2,4-thiadiazin-5-…monomer57-447
100.066F;
BACE-1 in complex with compound #3monomer56-446
100QJJ;QJM;GOL;SO4;
Crystal structure of BACE1 with its inhibitormonomer57-447
99.47VTI;SO4;
APO structure of BACE1monomer57-447
99.47SO4;CL;URE;
Crystal structure of BACE1 with its inhibitormonomer57-447
99.47ZPZ;SO4;URE;CL;
Crystal structure of human beta secretase complexed with inhibitormonomer56-446
99.475HA;
BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-4-(((1S,3R)-3-(isonicotinamido)cyclohexyl)methyl)-…monomer57-447
100.03KU;
BACE-1 in complex with compound #18monomer56-446
100ZRD;GOL;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGANDmonomer57-447
99.746Z0;NA;DMS;
Design and synthesis of thiophene dihydroisoquinolins as novel BACE-1 inhibitorsmonomer63-453
100.01BC;ZN;NA;
Crystal structure of Human Bace-1 bound to inhibitormonomer56-446
99.47L00;
Crystal structure of human Beta-secretase complexed with inhibitormonomer56-446
99.47I02;
Crystal structure of human Beta-secretase complexed with L-L000430,469monomer56-446
99.463BN;
Crystal structure of human beta secretase complexed with inhibitormonomer56-446
99.47MY9;
Structure of Beta-Secretase Complexed with Inhibitormonomer56-446
100
New Aminoimidazoles as BACE-1 Inhibitors: From Rational Design to Ab- lowering in Brainmonomer56-446
98.77DMS;1B1;
BACE1 in complex with (S)-5-(3-chloro-5-(5-(prop-1-yn-1-yl)pyridin-3-yl)thiophen-2-yl)-2,5-dimethyl…monomer57-447
100.066J;
Structure of BACE-1 in complex with Ligand 13monomer56-446
99.47M7D;
Crystal structure of BACE1 in complex with hydroxyethylamine inhibitor 37monomer56-446
99.470K9;GOL;
Crystal Structure of BACE1 in complex with N-(3-((4S,5R)-2-amino-4-methyl-5-phenyl-5,6-dihydro-4H-1…monomer57-447
100.0IOD;DMS;C6R;
Crystal structure of BACE1 with its inhibitormonomer56-446
99.47SO4;
Crystal Structure of BACE1 in complex with N-{3-[(5R)-3-amino-2,5-dimethyl-1,1-dioxo-5,6-dihydro-2H…monomer56-446
100.0IOD;GOL;66F;
BACE-1 in complex with ligand 12monomer57-447
100.0IOD;GOL;DMS;0EW;
Crystal Structure of Beta-secretase complexed with Inhibitor OM00-3monomer56-446
100
Crystal structure of human Beta-secretase complexed with inhibitormonomer56-446
99.47I03;
Crystal structure of BACE1 with its inhibitormonomer57-447
99.47ZPY;SO4;
Crystal structure of BACE1 in complex with hydroxyethylamine-macrocyclic inhibitor 13monomer57-447
99.731R8;GOL;SO4;
BACE-1 complexed with compound 1monomer57-447
99.73AEF;
BACE-1 complexed with compound 4monomer57-447
99.73AED;
BACE-1 complexed with compound 2monomer57-447
99.72AEG;
Crystal Structure of BACE1 in complex with N-{3-[(4S)-2-amino-4-methyl-5,6-dihydro-4H-1,3-thiazin-4…monomer57-447
100.0IOD;NA;GOL;C6U;
Crystal Structure of BACE1 in complex with N-{3-[(5R)-3-amino-5-methyl-9,9-dioxo-2,9lambda6-dithia-…monomer57-447
100.0IOD;GOL;C7O;
BACE-1 in complex with (7aR)-7a-(5-cyanothiophen-2-yl)-6-(5-fluoro-4-methyl-6-(methylthio)pyrimidin…monomer58-447
100.0954;
Structure of BACE Bound to SCH734723monomer58-447
100TAR;SC7;
Structure of BACE Bound to 5-(3-(5-chloropyridin-3-yl)phenyl)-5-cyclopropyl-2-imino-3-methylimidazo…monomer58-447
1000KQ;TLA;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH (1SR,2SR)-2-((R)-2-amino-5,5-difluoro-4-methyl-5,6-dihy…monomer57-446
99.74NA;DMS;5T7;GOL;ACT;
Structure of BACE Bound to SCH736062monomer58-447
100TAR;BDW;
BACE-1 in complex with (4aR,7aS)-7a-(2,6-difluorophenyl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-…monomer58-447
100.060T;
Crystal Structure of Human BACE-1 in Complex with amino-1,4-oxazine compound 4monomer60-449
100.0D9W;
BACE-1 in complex with (7aR)-7a-(5-cyanothiophen-2-yl)-6-(5-fluoro-4-methyl-6-(methylamino)pyrimidi…monomer58-447
100.0TLA;60S;
BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-4-(((1S,3R)-3-(cyclopentylamino)cyclohexyl)methyl)…monomer58-447
100.0TLA;3KT;
BACE-1 incomplex with (7aR)-7a-(4-(3-cyanophenyl)thiophen-2-yl)-6-(5-fluoro-4-methoxypyrimidin-2-yl…monomer58-447
100.0TLA;60W;
Crystal structure of bace1 with novel inhibitormonomer58-447
99.47SO4;URE;PEG;
Structure of BACE Bound to 2-fluoro-5-(5-(2-imino-3-methyl-4-oxo-6-phenyloctahydro-1H-pyrrolo[3,4-d…monomer58-447
100TLA;10W;
Crystal structure of BACE1 complexed with an inhibitormonomer57-446
99.475HA;CL; 11×URE;SO4;
Human BACE-1 in complex with N-((1S,2R)-3-(cyclohexylamino)-2-hydroxy- 1-(phenylmethyl)propyl)-3-(e…monomer62-451
99.2VG7;
BACE-1 in complex with (7aR)-7a-(5-cyanothiophen-2-yl)-6-(4-ethoxy-5-fluoro-6-methylpyrimidin-2-yl)…monomer58-447
100.060U;
BACE crystal structure with tricyclic aminothiazine inhibitormonomer57-446
1004RY;
Structure of BACE Bound to SCH722924monomer58-447
100TAR;CS7;
BACE-1 in complex with (7aR)-7a-(4-(3-cyanophenyl)thiophen-2-yl)-6-(5-fluoropyrimidin-2-yl)-3-methy…monomer58-447
100.0TLA;60Y;
Structure of BACE Bound to 3-(5-((7aR)-2-imino-6-(6-methoxypyridin-2-yl)-3-methyl-4-oxooctahydro-1H…monomer58-447
100TLA;10O;
Structure of BACE Bound to SCH736201monomer58-447
100TAR;BDX;
Crystal structure of BACE1 with its inhibitormonomer57-446
99.47ZPX;SO4;URE;CL;
BACE-1 in complex with (4aR,7aS)-7a-(2,4-difluorophenyl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-…monomer58-447
100.060X;
BACE-1 incomplex with (7aR)-7a-(5-cyanothiophen-2-yl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-yl)…monomer58-447
100.060V;
Structure of BACE Bound to SCH727596monomer58-447
100314;TAR;
Structure of BACE Bound to 2-imino-5-(3'-methoxy-[1,1'-biphenyl]-3-yl)-3-methyl-5-phenylimidazolidi…monomer58-447
1000KM;TLA;
Structure of BACE Bound to SCH735310monomer58-447
100TAR;CS9;
Structure of BACE Bound to SCH709583monomer58-447
100316;TAR;
Structure of BACE Bound to SCH723873monomer58-447
100.0TAR;BDV;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5S)-2-amino-…monomer57-446
99.74NA;DMS;1H6;
Crystal Structure of BACE with amino thiazine inhibitor LY2886721monomer57-446
100.03YS;GOL;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,6S)-2-amino-…monomer57-446
99.74NA;DMS;1HM;
Structure of BACE Bound to 2-imino-3-methyl-5,5-diphenylimidazolidin-4-onemonomer58-447
1000KK;TLA;
Structure of BACE Bound to SCH726222monomer58-447
100318;TAR;
Structure of BACE bound to SCH743813monomer57-446
100.074A;TLA;
Crystal Structure of human Beta Secretase complexed with IXSmonomer57-446
99.47IXS;
Structure of BACE Bound to SCH713601monomer58-447
100.0TAR;BDO;
Structure of BACE Bound to SCH723871monomer58-447
100.0TAR;BDQ;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-4-di…monomer57-446
99.74NA;DMS;1HQ;
BACE1 in complex with 4-(3-(furan-2-carboxamido)phenyl)-1-methyl-5-oxo-4-phenylimidazolidin-2-imini…monomer58-447
100TLA;66H;
Structure of BACE Bound to (S)-3-(5-(2-imino-1,4-dimethyl-6-oxohexahydropyrimidin-4-yl)thiophen-3-y…monomer58-447
100TLA;13W;
Structure of BACE Bound to 2-((7aR)-7a-(4-(3-cyanophenyl)thiophen-2-yl)-2-imino-3-methyl-4-oxohexah…monomer58-447
100TLA;10Q;
Structure of BACE Bound to (R)-5-cyclopropyl-2-imino-3-methyl-5-(3-(5-(prop-1-yn-1-yl)pyridin-3-yl)…monomer58-447
1000KR;TLA;
Structure of BACE Bound to SCH745966monomer58-447
100SC6;TAR;
Structure of BACE Bound to 2-imino-3-methyl-5-phenyl-5-(3-(pyridin-3-yl)phenyl)imidazolidin-4-onemonomer58-447
1000KP;TLA;
BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-4-(((R)-1-(2-cyclopentylacetyl)pyrrolidin-3-yl)met…monomer58-447
100.03KO;
A multiconformer ligand model of 5T5 bound to BACE-1monomer57-446
99.73NA;DMS;5T5;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH {(1R,2R)-2-[(R)-2-Amino-4-(4-difluoromethoxy-phenyl)-4,…monomer57-446
99.735T5;NA;DMS;
BACE crystal structure with bicyclic aminothiazine inhibitormonomer57-446
1004RZ;GOL;
BACE-1 in complex with compound #22monomer57-446
100ZR7;
Structure of Bace-1 in complex with Ligand 8monomer57-446
99.73HRV;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5R)-2-amino-…monomer57-446
99.74NA;DMS;1H7;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-[3-[(3-chloro-8-quinolyl)amino]phenyl]-5-methyl-2,6-d…monomer57-446
99.73NA;DMS;5T8;
Structure of BACE Bound to 3-(5-((7aR)-2-imino-6-(3-methoxypyridin-2-yl)-3-methyl-4-oxooctahydro-1H…monomer58-447
100.0TLA;10V;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-4-me…monomer57-446
99.73NA;DMS;1H8;
BACE-1 in complex with 2-(((1R,3S)-3-(((R)-4-(2-cyclohexylethyl)-2-iminio-1-methyl-5-oxoimidazolidi…monomer58-447
100.0TLA;3KW;
Structure of BACE Bound to SCH710413monomer58-447
100TAR;BDJ;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-5,5-…monomer57-446
99.73NA;DMS;1HO;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Ethoxy-pyridine-2-carboxylic acid [3-((R)-2-amino-5,5…monomer57-446
99.74NA;DMS;6T9;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5R,6R)-2-ami…monomer57-446
99.73NA;DMS;1HH;
Crystal Structure of BACE1 in complex with N-{3-[(4R,5R,6R)-2-amino-5-fluoro-4,6-dimethyl-5,6-dihyd…monomer57-446
100.0IOD;0QQ;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGANDmonomer57-446
99.73WZV;NA;DMS;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH (4S)-4-[3-(5-chloro-3-pyridyl)phenyl]-4-[4-(difluoromet…monomer57-446
99.745T6;DMS;NA;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,5R)-2-amino-…monomer57-446
99.74NA;DMS;1H5;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5R,6S)-2-ami…monomer57-446
99.73NA;DMS;1HG;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,6R)-2-amino-…monomer57-446
99.73NA;DMS;1HJ;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,6S)-2-amino-…monomer57-446
99.73NA;DMS;1HL;
Structure of bace (beta secretase) in Complex with EV0monomer57-446
99.74EV0;
Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(2,6-dimethoxy-benzyl)-p…monomer57-446
99.73F1I;
Crystal Structure of BACE1 in complex with N-{3-[(3S)-1-amino-5-fluoro-3-methyl-3,4-dihydro-2,6-nap…monomer57-446
100.0IOD;GOL;GUC;
Crystal Structure of BACE1 in complex with N-{3-[(4S)-2-amino-4-methyl-4H-1,3-thiazin-4-yl]-4- fluo…monomer57-446
100.0IOD;GOL;H3C;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGANDmonomer57-446
99.738T3;NA;DMS;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGANDmonomer57-446
99.73XK0;NA;DMS;
Crystal Structure of BACE1 in complex with N-{3-[(4R,5R,6R)-2-amino-5-fluoro-4,6-dimethyl-5,6-dihyd…monomer57-446
100.0IOD;GOL;DMS;C83;
human Bace (beta secretase) in complex with Cyclohexanecarboxylic acid (2-(2-am ino-6-phenoxy-4H-qu…monomer60-449
100.0QUD;
Crystal structure of BACE1 in complex with OM99-2 at pH 5.0monomer57-446
100
BACE-1 IN COMPLEX WITH LIGAND 32397778monomer57-446
99.74III;CL;
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH Pep#3monomer58-447
100CL;
Crystal structure of the human BACE1 catalytic domain in complex with 4-(4-fluoro-benzyl)-piperazin…monomer57-446
99.73F1K;
Crystal Structure of Human Beta Secretase in Complex with NVP-AVI326monomer59-447
100.00GO;
Crystal Structure of Hydroxyethyl Secondary Amine-based Peptidomimetic Inhibitor of Human Beta-Secr…monomer59-447
100.0F2I;
BACE1 in complex with 4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(3-isopropoxybenzyl)-1,3,8-triazaspi…monomer58-446
99.464QA;
Structure of BACE in complex with (S)-4-(3-chloro-5-(5-(prop-1-yn-1-yl)pyridin-3-yl)thiophen-2-yl)-…monomer58-446
100.00V6;
Crystal Structure of Human Beta Secretase Complexed with inhibitormonomer58-446
99.45SO4;35A;
BACE-1 in complex with compound #18monomer58-446
100QJP;GOL;SO4;
BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-1-methyl-5-oxo-4-(((1S,3R)-3-(3-phenylureido)cyclo…monomer58-446
100.0TLA;779;
Crystal structure of bace1 with its inhibitormonomer58-446
99.47SO4;0U4;URE;
Crystal structure of Bace1 with its inhibitormonomer58-446
99.47SO4;
Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functiona…monomer58-446
100.0P6U;IOD;EDO;
Preclinical characterization of AZD3839, a novel clinical candidate BACE1 inhibitor for the treatme…monomer57-445
99.73ACT;NA;32D;
Bace1 with the aminohydantoin Compound R-58monomer59-447
100.0569;
BACE-1 in complex with HEA-type macrocyclic inhibitor, MV078571monomer58-446
100.00XA;ACT;GOL;
BACE1 in complex with 8-(3-((1-aminopropan-2-yl)oxy)benzyl)-4-(cyclohexylamino)-1-(3-fluorophenyl)-…monomer58-446
99.464QD;
Crystal structure of human Beta secretase complexed with inhibitormonomer58-446
99.4632P;
Structure of bace (beta secretase) in complex with inhibitormonomer58-446
100.0EV3;GOL;
Design and Synthesis of Potent BACE-1 Inhibitors with Cellular Activity: Structure-Activity Relatio…monomer59-447
100.01LI;
Crystal structure of BACE with amino thiazine inhibitor LY2811376monomer58-446
100.04B2;GOL;
Crystal structure of BACE1 in complex with aminoquinoline inhibitor 6monomer60-448
100.068J;GOL;
Bace1 with the aminohydantoin Compound 37monomer59-447
100.0X45;
Crystal structure of beta-secretase bound to a potent and highly selective inhibitor.monomer58-446
100ZPQ;
Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(5-chloro-2-isopropoxy-3…monomer58-446
99.47F1M;
Structure of BACE-1 Bound to (7aR)-6-benzoyl-7a-(4-(3-cyanophenyl)thiophen-2-yl)-3-methyl-4-oxohexa…monomer58-446
100.010J;
Discovery of Pyrrolidine-based b-Secretase Inhibitors: Lead Advancement through Conformational Desi…monomer58-446
100.0508;SO4;GOL;
New substrate binding pockets for beta-secretase.monomer58-446
100
Crystal Structure of Human BACE-1 in Complex with Compound NB-360 (compound 54)monomer59-447
100.0SLK;
BACE crystal structure with bicyclic aminothiazine fragmentmonomer58-446
1004RW;GOL;
BACE crystal structure with hydroxy pyrrolidine inhibitormonomer58-446
100DKJ;GOL;
Crystal structure of Beta-secretase bound to a long inhibitor with additional upstream residues.monomer58-446
100
Crystal Structure of Unbound Beta-Secretase Catalytic Domain.monomer58-446
100
BACE1 in complex with 8-benzyl-4-(cyclohexylamino)-1-(3-fluorophenyl)-7-methyl-1,3,8-triazaspiro[4.…monomer58-446
99.464QF;
Crystal Structure of Human Beta Secretase Complexed with inhibitormonomer58-446
99.46SO4;712;
Crystal structure of GRL-8234 bound to BACE (Beta-secretase)monomer58-446
100BSD;
Crystal Structure of beta secetase in complex with 2-amino-3-methyl-6-((1S, 2R)-2-phenylcyclopropyl…monomer58-446
100.0IOD;GOL;B00;
Crystal Structure of beta secetase in complex with 2-amino-6-((1S,2R)-2-(3'-methoxybiphenyl-3-yl)cy…monomer58-446
100.0IOD;GOL;0B1;
Crystal structure of human BACE-1 bound to Compound 36monomer58-446
100.03VP;IOD;DMS;
Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(5-bromo-2,3-dimethoxy-b…monomer58-446
99.71F1L;
Crystal structure of BACE1 bound to inhibitormonomer58-446
99.46SO4;GOL;5MS;
Crystal structure of the human BACE1 catalytic domain in complex with 4-(4-fluoro-benzyl)-piperazin…monomer58-446
99.19F1J;
Crystal Structure of BACE1 in complex with N-{3-[(9S)-7-amino-2,2-difluoro-9-(prop-1-yn-1-yl)-6-oxa…monomer58-446
100.0IOD;GOL;GX6;
Design and Synthesis of Potent BACE-1 Inhibitors with Cellular Activity: Structure-Activity Relatio…monomer59-447
100.0SO4;GOL;2LI;
Crystal Structure of BACE1 in complex with N-{3-[(4S,6S)-2-amino-4-methyl-6-(trifluoromethyl)-5,6-d…monomer58-446
100.0IOD;GOL;C86;
Crystal Structure of human beta-secretase (BACE) in the presence of an inhibitor (2)monomer59-447
100.0LIQ;
Structure of BACE1 in complex with N-(3-((4R,5R,6S)-2-amino-6-(1,1-difluoroethyl)-5-fluoro-4-methyl…monomer58-446
100.0IOD;GOL;DMS;0B5;
Bace1 with the aminohydantoin Compound 29monomer59-447
100.0593;
Crystal structure of human beta secretase complexed with NVP-AMK640monomer58-446
100.0
BACE crystal structure with tricyclic aminothiazine inhibitormonomer58-446
1004RX;
Design and synthesis of hydroxyethylamine (hea) BACE-1 inhibitors: prime side chromane-containing i…monomer58-446
99.48C6A;
Crystal Structure of BACE1 in complex with N-{3-[(4R)-2-amino-4-(prop-1-yn-1-yl)-5,6-dihydro-4H-1,3…monomer58-446
100.0IOD;GOL;GTU;
Structure of Bace (beta secretase) in complex with ligand EV2monomer58-446
100.0EV2;
Crystal structure of beta-secretase bond to an inhibitor with Isophthalamide Derivatives at P2-P3monomer58-446
10023I;
CRYSTAL STRUCTURE OF BETA-SITE APP-CLEAVING ENZYME 1 COMPLEXED WITH N-(3-((4AS,7AS)-2-AMINO-4,4A,5,…monomer58-446
100.07H3;
Crystal structure of human BACE-1 bound to Compound 6monomer58-446
100.03WP;IOD;NA;GOL;DMS;
Crystal structure of the human BACE1 catalytic domain in complex with N-(1-benzyl-piperidin-4-yl)-4…monomer58-446
99.72F1H;
Crystal structure of BACE1 with its inhibitormonomer58-446
99.46VSI;
Crystal Structure of Human Beta Secretase in Complex with NVP-BVI151monomer58-446
100.00GU;IOD;
Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(5-chloro-2-isopropoxy-3…monomer58-446
100.0F1N;
BACE-1 in complex with ELN380842monomer59-447
100.0842;
Crystal Structure of a cycloamide-urethane-derived novel inhibitor bound to human brain memapsin 2 …monomer58-446
100MMI;
X-ray structure of BACE1 in complex with a bicyclic isoxazoline carboxamide as the P3 ligandmonomer58-446
100.0GHJ;GOL;URE;
Structure of BACE1 complex with a syn-HEA-type inhibitormonomer59-447
100
Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functiona…monomer58-446
100.074B;IOD;NA;GOL;DMS;CL;
Crystal structure of BACE1 with its inhibitormonomer59-447
100.0
Crystal Structure of Human BACE-1 in Complex with CNP520monomer59-446
100.0BUH;
Diethylaminosulfur Trifluoride-Mediated Intramolecular Cyclization of 2-hydroxy-benzylureas to Fuse…monomer60-447
100.01W0;DMS;
Crystal Structure of Human Beta Secretase in Complex with NVP-BQQ711monomer59-446
100.00GS;
Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in Brainmonomer58-445
100.02FB;
Crystal structure of BACE1 in complex with aminoquinoline compound 1monomer60-447
100.0IOD;68M;GOL;
BACE1 IN COMPLEX WITH compound 3 (NB-641)monomer59-446
100.0SKW;
Crystal Structure of Human Beta Secretase in Complex with NVP-BXD552, derived from a soaking experi…monomer59-446
100.0BXD;
Diethylaminosulfur Trifluoride-Mediated Intramolecular Cyclization of 2-hydroxy-benzylureas to Fuse…monomer60-447
100.01W2;ACT;
Crystal Structure of Human Beta Secretase in Complex with NVP-BXQ490monomer59-446
100.0BXQ;
Aminoimidazoles as BACE-1 Inhibitors. X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMP…monomer58-445
100.0ACT;QN7;
Apo Structure of BACE (Beta Secretase)monomer60-447
100.0IOD;
Crystal Structure of Human BACE-1 in Complex with Compound 38a (NB-854)monomer60-447
100.0SL8;
Crystal Structure of Human Beta Secretase in Complex with NVP-BUR436, derived from a soaking experi…monomer59-446
100.00GT;
Crystal structure of BACE1 in complex with 2-aminooxazoline 4-fluoroxanthene inhibitor 49monomer60-447
100.0IOD;3LO;GOL;
Design and Synthesis of BACE1 Inhibitors with In Vivo Brain Reduction of beta-Amyloid Peptides (COM…monomer58-445
100.0ACT;NA;7F3;
Crystal structure of human Beta Secretase complexed with I21monomer59-446
99.47I21;
Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in Brainmonomer58-445
100.0DMS;54M;
Crystal structure of BACE1 with its inhibitormonomer60-447
99.47
Design and Synthesis of BACE1 Inhibitors with In Vivo Brain Reduction of beta-Amyloid Peptides (COM…monomer58-445
100.0ACT;I6X;
co-crystal structure of BACE with inhibitor AM-6494monomer60-447
100.0IOD;GOL;P6J;
Diethylaminosulfur Trifluoride-Mediated Intramolecular Cyclization of 2-hydroxy-benzylureas to Fuse…monomer60-447
100.01W1;ACT;DMS;
Crystal structure of BACE1 in complex with (Z)-fluoro-olefin containing compound 15monomer60-447
100.0U64;IOD;
New Aminoimidazoles as BACE-1 Inhibitors: From Rational Design to Ab- lowering in Brainmonomer58-445
100.06T6;
Structure of Bace-1 (Beta-Secretase) in complex with : N-(3-((1R,5S,6R)-3-amino-5-methyl-2-oxa-4-az…monomer60-447
100.0IOD;GOL;SO4;EJ7;
Crystal Structure of Human Beta Secretase in Complex with Compound 11amonomer59-446
100.01YS;
New Aminoimidazoles as BACE-1 Inhibitors: From Rational Design to Ab- lowering in Brainmonomer58-445
100.0ACT;6TG;
Crystal structure of BACE complex with BMC022monomer59-446
100.0E51;
Crystal structure of BACE complex with BMC025monomer59-446
100.0AFJ;
Crystal structure of human beta-secretase in complex with NVP-AFJ144monomer59-446
100.0AFJ;
Bace1 with the aminohydantoin Compound S-34monomer59-446
100.0X17;
Fragment Based Discovery and Optimisation of BACE-1 Inhibitorsmonomer60-447
100.0IOD;GOL;EV4;
Crystal structure of BACE complex with BMC020 hydrolyzedmonomer59-446
100.0GOL;E7A;
Human bace-1 complex with bjc060monomer59-446
100.0BJC;
Crystal Structure of Human Beta Secretase in Complex with compound 11dmonomer59-446
100.01YT;
Crystal structure of BACE complex with BMC001monomer59-446
100.0E4Y;
Crystal structure of human beta secretase complexed with NVP-AUR200monomer59-446
100.0
Crystal Structure of Human Beta Secretase in Complex with NVP-BXD552, derived from a co-crystalliza…monomer59-446
100.0BXD;
Crystal structure of BACE complex with BMC021monomer59-446
100.0AR9;
Crystal structure of BACE complex with BMC013monomer59-446
100.0E74;
Potent Beta-Secretase 1 hydroxyethylene Inhibitormonomer59-446
100.0MV7;
Crystal structure of BACE complex with BMC002monomer59-446
100.0BAV;
Crystal structure of BACE complex with BMC019 hydrolyzedmonomer59-446
100.0GOL;E77;
Bace1 in complex with the aminohydantoin Compound 4gmonomer59-446
100.0Z81;
Crystal structure of human beta-secretase in complex with NVP-BAV544monomer59-446
100.0BAV;
Crystal structure of human beta-secretase in complex with NVP-ARV999monomer59-446
100.0AR9;
Crystal Structure of the Bace complex with AXQ093, a macrocyclic inhibitormonomer59-446
100.0AXQ;
Crystal structure of BACE complex with BMC023monomer59-446
100.0AXQ;
Crystal structure of BACE complex with BMC014monomer59-446
100.00BI;
Human BACE-1 complex with NB-216monomer59-446
100.00BI;
BACE1 in complex with a macrocyclic inhibitormonomer59-446
100.0L3M;SO4;
BACE1 in complex with a macrocyclic inhibitormonomer59-446
100.0L3J;
Crystal structure of BACE complex with BMC008monomer59-446
100.0E5P;
Crystal structure of BACE1 in complex with 2-aminooxazoline-3-azaxanthene inhibitor 2monomer60-447
100.0IOD;GOL;SO4;68L;
Rational Design and Synthesis of Aminopiperazinones as Beta Secretase (BACE) Inhibitorsmonomer59-446
100.018P;SO4;
BACE-1 in complex with ELN475957monomer59-446
100.0957;
SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitors.monomer59-446
100.01BL;
SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitorsmonomer59-446
100.0957;
Crystal structure of BACE complex with BMC007monomer59-446
100.0E5D;
Crystal structure of BACE complex with BMC026monomer59-446
100.0E4J;SO4;
Crystal structure of beta-secretase 1 in complex with selective beta-secretase 1 inhibitormonomer59-446
100.0586;SO4;
Bace-1 with Compound 3monomer59-446
100.0454;
Structure based design, synthesis and SAR of cyclic hydroxyethylamine (HEA) BACE-1 inhibitorsmonomer59-446
100.0QBH;
Human BACE-1 COMPLEX WITH AYH011monomer59-446
100.0AYH;
Crystal structure of BACE complex with BMC023monomer59-446
100.0E5A;
Bace-1 inhibitor complexmonomer59-446
100.01QU;
Crystal structure of BACE complex with BMC009monomer59-446
100.0E6P;
Crystal structure of BACE complex with BMC015monomer59-446
100.0E5V;
Crystal structure of BACE1 in complex with biarylspiro aminooxazoline 6monomer60-447
100.0IOD;DWA;DMS;
Crystal Structure of Human Beta Secretase in Complex with compound 12amonomer59-446
100.01YU;
Crystal Structure of the Bace complex with BDF488, a macrocyclic inhibitormonomer59-446
100.0AXF;
Crystal structure of BACE complex with BMC024monomer59-446
100.0AXF;
Hydroxyethylamine-based inhibitors of BACE1: P1-P3 macrocyclization can improve potency, selectivit…monomer59-446
100.01QT;
Structure of BACE complexed to compound 1monomer59-446
98.97XX4;
Crystal Structure of Human Beta Secretase in Complex with BFG356monomer59-446
100.03P5;
Crystal structure of BACE complex with BMC011monomer59-446
100.0E61;
Crystal Structure of Human Beta Secretase in Complex with NVP-BUR436, derived from a co-crystalliza…monomer59-446
100.00GT;
Crystal structure of BACE complex with BMC018monomer59-446
100.0E4G;
Crystal structure of BACE complex with BMC003monomer59-446
100.0E6V;
Crystal structure of BACE complex with BMC010monomer59-446
100.0E6M;
Co-crystal of BACE1 with compound 0211monomer59-446
100.05E7;
BACE-1 complexed with compound 3monomer60-447
99.72AEH;
Crystal structure of BACE complex with BMC017monomer59-446
100.0E6J;
Crystal structure of beta-secretase complexed with an amino-ethylene inhibitormonomer59-446
100.0FRP;
Crystal Structure of human beta-secretase (BACE) in the presence of an inhibitormonomer59-446
100.0PO4;LIJ;
Potent beta-secretase 1 inhibitormonomer59-446
100.0929;
Potent and selective isophthalamide S2 hydroxyethylamine inhibitor of BACE1monomer59-446
100.0PO4;MR0;
Crystal structure of BACE complex with BMC004monomer59-446
100.0E6S;
Crystal structure of BACE1 complexed with an inhibitormonomer60-447
100.05HA;CL;
BACE (Beta Secretase) in complex with a nanomolar non-peptidic inhibitormonomer60-447
100.0IOD;L01;
Fragment based discovery and optimisation of bace-1 inhibitorsmonomer60-447
100.0EV6;IOD;
Beta-secretase 1 complexed with statine-based inhibitormonomer59-446
100.0757;IPA;
Crystal structure of BACE complex with BMC005monomer59-446
100.0E6Y;
Crystal structure of BACE complex with BMC016monomer59-446
100.0E4A;
Discovery of aminoheterocycles as a novel beta-secretase inhibitor classmonomer59-446
100.0B35;
Crystal Structure of BACE-1 in complex with AHM178monomer59-446
100.0XLI;
Structure of BACE1 complex with 2-thiophenyl HEA-type inhibitormonomer60-447
100
Crystal structure of BACE1 in complex with 2-aminooxazoline 3-azaxanthene inhibitor 28monomer60-446
100.0IOD;43K;GOL;
BACE-1 in complex with a HEA-macrocyclic type inhibitormonomer60-446
100.00LG;
Crystal structure of BACE1 at pH 7.0monomer60-446
100.0
Crystal structure of BACE1 in complex with 2-aminooxazoline 3-aza-4-fluoro-xanthene inhibitor 22monomer60-446
100.0IOD;GOL;3UT;
BACE-1 in complex with HEA-macrocyclic inhibitor, MV078512monomer60-446
100.00N1;
Crystal structure of BACE1 in complex with a 2-aminooxazoline 4-azaxanthene inhibitormonomer60-446
100.03LL;IOD;GOL;
Crystal structure of BACE1 in complex with 2-aminooxazoline-3-azaxanthene compound 12monomer60-446
100.0IOD;8QV;GOL;
Crystal structure of BACE1 in complex with hydroxyethylamine-macrocyclic inhibitor 19monomer60-446
100.0IOD;1R6;GOL;
BACE1 compound 23monomer62-448
100.0B7T;
Crystal structure of BACE1 in complex with aminooxazoline xanthene 9lmonomer60-446
100.0IOD;DWB;GOL;DMS;
Compound 10monomer60-446
100.0GOL;IOD;5QU;
(4~{S},6~{S})-4-[2,4-bis(fluoranyl)phenyl]-4-methyl-6-pyrimidin-5-yl-5,6-dihydro-1,3-thiazin-2-amin…monomer60-446
100.06WD;
Structure of beta-secretase complexed with inhibitormonomer60-446
1000GH;LPD;
Bace1 with Compound 30monomer59-445
100.0472;
X-ray structure of Bace-1 in complex with compound 3.b.10monomer59-445
100.0310;
X-ray crystal structure of beta secretase complexed with compound 4monomer60-446
100.0IOD;DMS;7IP;GOL;
Crystal structure of BACE1 in complex with aminooxazoline xanthene 11amonomer60-446
100.0IOD;DWD;GOL;
Compound 18monomer60-446
100.0GOL;IOD;5QV;
(4~{S},6~{S})-4-[2,4-bis(fluoranyl)phenyl]-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-methyl-5,6-dihydro-1,…monomer60-446
100.0IOD;6WE;
X-ray crystal structure of beta secretase complexed with 4-(4-fluorobenzyl)piperidinemonomer60-446
100.0IOD;DMS;4FP;
Crystal structure of BACE1 in complex with aminoquinoline inhibitor 9monomer60-446
100.068K;
BACE1 in complex with inhibitor 5gmonomer60-446
100.0SO4;8W4;URE;
Pyrazolyl and Thienyl Aminohydantoins as Potent BACE1 Inhibitorsmonomer59-445
100.0591;
X-ray crystal structure of beta secretase complexed with 1-amino-isoquinolinemonomer60-446
100.0IOD;DMS;1SQ;
Pyrazolyl and Thienyl Aminohydantoins as Potent BACE1 Inhibitorsmonomer59-445
100.0532;
X-ray crystal structure of beta secretase complexed with compound 5monomer60-446
100.0IOD;DMS;CMZ;
X-ray crystal structure of beta secretase complexed with compound 3monomer60-446
100.0IOD;DMS;6IP;
Crystal Structure of beta secetase in complex with 2-amino-3,6-dimethyl-6-(2-phenylethyl)-3,4,5,6-t…monomer60-446
100.0GOL;IOD;0B3;
X-ray crystal structure of beta secretase complexed with compound 6amonomer60-446
100.0IOD;DMS;8IP;GOL;
Crystal structure of BACE1 in complex with 3-(2-amino-6-(o-tolyl)quinolin-3-yl)-N-(3,3-dimethylbuty…monomer60-446
100.0IOD;GOL;6BS;
X-ray crystal structure of beta secretase complexed with compound 7monomer60-446
100.0IOD;DMS;IP6;
Bace1 with Compound 38monomer59-445
100.0BX2;
Structure of Bace-1 (Beta-Secretase) in Complex with 3-(2-Aminoquinolin-3-yl)-N-(cyclohexylmethyl)p…monomer60-446
100.0IOD;GOL;3RU;
Crystal structure of BACE1 at pH 4.5monomer60-446
100.0
X-ray crystal structure of beta secretase complexed with compound 8bmonomer60-446
100.0IOD;DMS;IP7;
BACE1 in complex with a macrocyclic inhibitormonomer59-445
100.0L4J;SO4;
Bace-1 with the aminopyridine Compound 32monomer59-445
100.0625;
Crystal structure of BACE1 at pH 5.0monomer60-446
100.0
Crystal structure of BACE1 in complex with aminooxazoline xanthene inhibitor 2monomer60-446
100.03LN;IOD;
Fragment Based Discovery and Optimisation of BACE-1 Inhibitorsmonomer60-446
100.0IOD;EV5;
X-ray crystal structure of beta secretase complexed with compound 6bmonomer60-446
100.0IOD;DMS;9IP;
Structure of Bace-1 (Beta-Secretase) in Complex with 6-(Thiophen-3-yl)quinolin-2-aminemonomer60-446
100.0IOD;RSV;
Crystal structure of beta-site app-cleaving enzyme 1 (BACE-DB-MUT) complex with N-(N-(4- acetamido-…monomer60-446
1000VB;IOD;
Structure of Bace-1 (Beta-Secretase) in Complex with (2R)-N-((2S,3R)-1-(benzo[d][1,3]dioxol-5-yl)-3…monomer60-446
100.0IOD;GOL;0KN;
Structure of Bace-1 (Beta-Secretase) in complex with N-((2S,3R)-1-(4-fluorophenyl)-3-hydroxy-4-((6'…monomer60-446
100.0IOD;GOL;0MP;
Crystal structure of beta secetase in complex with 2-amino-3-methyl-6-((1S,2R)-2-(3'-methylbiphenyl…monomer60-446
100.0GOL;B02;
Structure of Bace-1 (Beta-Secretase) in complex with (R)-3-(2-amino-6-o-tolylquinolin-3-yl)-N-((R)-…monomer60-446
100.0IOD;GOL;3RS;
Crystal Structure of beta secetase in complex with (6S)-2-amino-3,6-dimethyl-6-[(1R,2R)-2-phenylcyc…monomer60-446
100.0IOD;GOL;DMS;0B4;
Crystal structure of BACE complex withBMC006monomer59-445
100.0E5Y;
Bace-1 in complex with a norstatine type inhibitormonomer59-445
100.0038;
1,4-Oxazine BACE1 inhibitorsmonomer60-446
100.052K;IOD;CL;
crystal structure of beta-site app-cleaving enzyme 1 (bace-wt) complex with N-(N-(4-amino-3,5- dich…monomer60-446
1000VA;IOD;
Structure of Bace-1 (Beta-Secretase) in Complex with 2-((2-Amino-6-o-tolylquinolin-3-yl)methyl)-N-(…monomer60-446
100.0IOD;GOL;RVI;
X-ray crystal structure of beta secretase complexed with 2-aminoquinolinemonomer60-446
100.0IOD;DMS;2AQ;
Crystal structure of BACE1 at pH 4.0monomer60-446
100.0
X-ray crystal structure of beta secretase complexed with N~3~-benzylpyridine-2,3-diaminemonomer60-446
100.0IOD;DMS;8AP;
Structure of Bace-1 (Beta-Secretase) in Complex with 3-(2-Amino-6-o-tolylquinolin-3-yl)-N-cyclohexy…monomer60-446
100.0IOD;GOL;RTN;
Structure of Bace-1 (Beta-Secretase) in Complex with 6-(2-(3,3-Dimethylbut-1-ynyl)phenyl)quinolin-2…monomer60-446
100.0IOD;RTH;
Structure of BACE1 complex with a HEA-type inhibitormonomer60-446
100
Structure of Bace-1 (Beta-Secretase) in Complex with 3-(2-Aminoquinolin-3-yl)-N-cyclohexyl-N-methyl…monomer60-446
100.0IOD;GOL;RTM;
Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with (2S)-2-((3S)-3-(acetyla…monomer60-446
100PB7;IOD;
Human BACE-1 in complex with 3-(1,1-dioxidotetrahydro-2H-1,2-thiazin- 2-yl)-5-(ethylamino)-N-((1S,2…monomer62-447
99.2C44;
Human BACE-1 in complex with 4-ethyl-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluoromethyl)…monomer62-447
99.2ZY0;
Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-…monomer62-447
99.19VG4;
Human BACE-1 in complex with 3-(ethylamino)-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluoro…monomer62-447
99.19VG6;
Human BACE-1 in complex with 7-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl(methyl)amino)-1-…monomer62-447
99.2ZY1;
Human BACE-1 in complex with 1-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-…monomer62-447
99.2ZYE;
Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-…monomer62-447
99.2XFI;
Human BACE-1 in complex with 3-(1,1-dioxidotetrahydro-2H-1,2-thiazin- 2-yl)-5-(ethylamino)-N-((1S,2…monomer62-447
99.2CM8;
Design and synthesis of potent hydroxyethylamine (hea) bace-1 inhibitorsmonomer61-446
100.0916;
Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-…monomer62-447
99.19AA9;
Human BACE-1 in complex with 6-ethyl-1-methyl-N-((1S)-2-oxo-1-(phenylmethyl)-3-(tetrahydro-2H-pyran…monomer62-447
99.2ZY4;
Design and synthesis of potent hydroxyethylamine (hea) bace-1 inhibitorsmonomer61-446
100.0996;
Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-…monomer62-447
99.19VG5;
Bace1 in complex with the aminohydantoin Compound 102monomer60-445
100.0ZOO;
Human BACE-1 in complex with 8-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-…monomer62-447
99.2ZY2;
Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-…monomer62-447
99.2VG5;
Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-…monomer62-447
99.2VG3;
Human BACE-1 in complex with 7-ethyl-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluoromethyl)…monomer62-447
99.2CM7;
Human BACE-1 in complex with N-((1S,2R)-1-benzyl-2-hydroxy-3-((1,1,5- trimethylhexyl)amino)propyl)-…monomer62-447
99.2VG0;
Aminoimidazoles as BACE-1 Inhibitors. X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMP…monomer60-445
100.0ACT;S8Z;
Human BACE-1 in complex with 6-(ethylamino)-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)am…monomer62-447
99.2ZY3;GOL;
Bace1 in complex with the aminopyridine Compound 44monomer59-444
100.0879;
X-ray structure of Bace-1 in complex with compound 6gmonomer60-445
100.0411;
Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with BMS-693391 AKA (2S)-2-(…monomer60-445
100PB0;
BACE1 with Compound 1monomer59-444
100.0251;
Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with (2S)-2-((3R)-3-acetamid…monomer60-445
100PB8;
Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in Brainmonomer61-445
100.0WM9;
BACE1 with Compound 2monomer60-444
100.0462;
Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in Brainmonomer62-445
100.0KGG;
Lead Generation of BACE1 Inhibitors by Coupling Non-amidine New Warheads to a Known Binding Scaffoldmonomer62-445
100.0GMF;ACT;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6ej2.1.Amonomer0.8637-445
B7E;99.60

5 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 26ej2.1.Amonomer0.8237-420
B7E;97.22
Isoform 36ej2.1.Amonomer0.8037-401
99.56
Isoform 46ej2.1.Amonomer0.8137-376
96.50
Isoform 56ej2.1.Amonomer0.852-345
96.00
Isoform 66ej3.1.Amonomer0.832-323
93.33